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A report on the Genomics, Proteomics and Bioinformatics
Thematic Meeting during the 2003 American Society for
Biochemistry and Molecular Biology (ASBMB) Annual
Meeting, San Diego, USA, 11-15 April 2003.
April 2003 marked the fiftieth anniversary of the discovery
of the double-helical structure of DNA and also the
announcement of the finished human genome sequence. The
period between the first outline of the DNA double-helix and
the grand revelation of the human genome has yielded the
complete genome sequences of many other organisms. It
was apt that the theme of the 2003 ASBMB Annual Meeting
was ‘Translating the Genome’, referring to the challenge of
converting sequence information into biological insights;
talks at the meeting highlighted various approaches being
developed to meet this challenge.
Stephen Young (University of California, San Francisco,
USA) described gene-trapping vectors for large-scale
insertional mutagenesis and expression studies of mouse
genes. The vectors contain the -galactosidase gene (plus a
resistance marker) with an upstream splice-acceptor site.
A vector is electroporated into mouse embryonic stem (ES)
cells, where it integrates randomly into the genome. Inser-
tions within a coding sequence that allow the reporter to
be functionally spliced are indicated by the growth of
drug-resistant clones expressing -galactosidase. Inser-
tion sites can be identified by PCR sequencing of DNA
flanking the insertion. The BayGenomics consortium
[http://baygenomics.ucsf.edu/overview/people.html], headed
by Young, has generated more than 7,000 cell lines repre-
senting insertions in 2,200 distinct genes, and they anticipate
generating thousands more every year. The value of the
insertional cell lines arises from the ability to generate from
them mouse lines, which can be used in two main lines of
investigation. First, the expression pattern of -galactosidase
in the developing embryo is a surrogate marker for the
expression pattern of the gene targeted by the insertion.
Cell-type- or tissue-specific expression at specific develop-
mental stages, which provides clues about gene function, can
therefore be analyzed. Second, the ES cell lines can be used
to generate mice with null alleles of the targeted genes. More
than 150 knockout mice have been generated by the consor-
tium and these too will be available for distribution. 
Brian Seed (Harvard Medical School, Boston, USA)
described an automated approach for identifying mam-
malian cDNAs that can activate specific signaling pathways
or transcription factors. A reporter system was constructed,
consisting of green fluorescent protein (GFP) controlled by a
signaling-responsive promoter in an easily transfectable
mammalian cell. In parallel, tens of thousands of clones
from a library of cDNAs in expression vectors were individu-
ally grown in 384-well plates and pooled into several groups
in two orthogonal groupings. DNA from each pool was used
to transfect reporter cells. Reporter gene activity indicated
the presence of a cDNA that could activate the particular
signaling pathway to which the reporter gene was engi-
neered to respond. The activating clone could be identified
from the combination of pools in which it was found. One
assay using an NFB-responsive GFP reporter revealed that
G-protein-coupled receptors can activate NFB. Modifica-
tions of the reporter system will allow the identification of
clones that activate other mammalian transcription factors
or signaling pathways.
Genes with similar expression profiles may be co-regulated
because they have similar functions, but it is also possible
that co-expressed genes lack an underlying functional con-
nection. This raises an important question: how can one dis-
tinguish sets of genes that are co-expressed because of
functional relatedness rather than simply by chance? Stuart
Kim and colleagues (Stanford University, USA) reasoned
that if genes are co-regulated because they are functionally
related, this relationship is likely to have been selected for
during evolution and one is therefore likely to see co-regula-
tion of those genes in different species. Kim and colleagues
examined whether a set of genes whose expression washighly correlated in, for example, Drosophila were also co-
expressed in human. Regulation of genes encoding compo-
nents of cellular complexes such as the ribosome and the
protein translation machinery showed the highest degree of
conservation, but others involved in signaling, transcription,
ubiquitin-mediated protein degradation and the cell-cycle,
as well as a number of uncharacterized genes, also showed
conserved co-regulation. Kim’s analysis suggests that two-
thirds of the genes that appear to be co-regulated in a single
species are in fact functionally related, given the conserva-
tion of their co-regulation. 
One of the most exciting technologies for studying gene
function to be developed in recent years is the use of RNA
interference (RNAi) to abrogate function. Michael Boutros
and colleagues from Norbert Perrimon’s lab (Harvard
Medical School) have extended this approach to the whole
genome in Drosophila. Boutros described automated
screens to test the effects on cell viability, cytokinesis, and
signaling of inhibiting essentially every gene. RNAi for each
Drosophila gene was achieved by in vitro transcription and
then transfection of cultured Drosophila cells in 384-well
plates. Phenotypes were determined by automated imaging
of cell morphology or by quantitatively measuring the
expression of a luciferase reporter gene. Using this
approach, genes could be clustered on the basis of similar
quantitative RNAi phenotypes. This strategy is also
amenable to double-mutant analysis; for instance, Boutros
reported that RNAi against the Ras GTPase-activating
protein (GAP) inhibits signaling in response to lipopolysac-
charide (LPS) in innate immunity, but inhibition of Ras1 is
epistatic to the GAP effect. 
Protein-interaction networks offer a means of deciphering
how proteins function in concert to bring about biological
functions. One concern with many high-throughput experi-
mental approaches for identifying protein interactions is the
high rate of false positives. Frederick Roth (Harvard Medical
School) presented a probabilistic approach for validating
protein interactions, which relies on the observation that
true interactions tend to form small-world networks and are
‘cliquish’. This means that the true interacting partners of a
given protein are more likely also to interact with each other,
compared to a random network. Roth’s model was devel-
oped by first assuming that all proteins interact with each
other with a certain weight (or probability), then assigning
weights on the basis of experimental evidence. It allowed
him to calculate the probability that a protein is part of a
previously partially defined core complex or that it interacts
with another protein.
An alternative method for identifying gene interactions is a
synthetic lethal screen. If cells lacking the function of either
of two genes are viable, but cells deficient in both genes are
inviable, a functional relationship between the two genes is
likely. Geneticists have used this approach for decades, but
Charles Boone and colleagues (University of Toronto,
Canada) have brought it into the post-genome era by
automating the testing of all pair-wise combinations of all
the viable single-gene deletions in yeast (approximately
5,000 genes). This approach allows genes to be ordered into
functional pathways: for instance, if genes X, Y and Z are all
‘synthetic lethal’ with gene A, it suggests that the former
three genes function in the same pathway. Boone and col-
leagues have performed dozens of screens to identify thou-
sands of interactions, and extended the use of the yeast
deletion collection to perform chemical-genetic interaction
screens. In these the idea is that deletion mutants sensitive
to a drug should be ‘synthetic lethal’ with the targets of the
drug, allowing the clustering of drug-response profiles with
synthetic genetic profiles. Boone and colleagues could thus
infer the action of the drug papuamide on Golgi transport
through its effect on the genes RIC1 and YPT6.
Marc Vidal (Dana Farber Cancer Institute, Boston, USA)
provided an overview of integrated approaches to studying
the proteome of Caenorhabditis elegans. His group began
by cloning nearly 12,000 different open reading frames into
Gateway vectors (from Invitrogen) by PCR amplification
using gene-specific primers from representative cDNA
libraries. This extensive resource, available through distribu-
tors, allows more representative genome-wide protein-inter-
action assays using techniques such as the yeast two-hybrid
system or protein microarrays, and also aids in genome
annotation. Vidal emphasized the importance of integrating
different predictions of gene interactions to improve correla-
tions; for instance, interaction networks derived from two-
hybrid analysis could be compared to the linkages derived
from gene-expression profiling studies and to ‘phenome’
clusters, which are generated based on the large-scale RNAi
phenotypes that are being simultaneously collected.
The bold and creative approaches presented at the meeting
engender optimism that the challenge of translating genome
sequence information into comprehensive biological insights
is being adequately tackled. Biologists of the future, celebrat-
ing the one-hundredth anniversary of DNA structure and the
fiftieth anniversary of the Human Genome Project, will
undoubtedly look back at the results of this and similar work
as the source of much of their deep understanding of biology.
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